Journal of Enzyme Inhibition and Medicinal Chemistry 2018

3 papers
The 2018 edition of the Journal of Enzyme Inhibition and Medicinal Chemistry featured research focused on the identification and optimization of novel enzyme modulators. A significant portion of the work utilized computational methodologies, such as pharmacophore-based discovery and allosteric site identification, to target specific enzymes. Notable studies included the exploration of acetylcholinesterase (AChE) modulators and the development of potent eosinophil peroxidase (EPO) inhibitors using 2-(phenylamino)aceto-hydrazides. Research also emphasized the structural optimization of chemical cores, such as the 3-amino-1,2,4-triazin-5(2H)-one scaffold, for the development of Fyn inhibitors. Prolific contributors during this period included Ana Martínez, Nuria E. Campillo, and Thierry Langer, among others. These studies reflect a trend in medicinal chemistry toward combining experimental tools with advanced binding investigations to refine therapeutic candidates for various biological targets. The year’s publications highlight a systematic approach to drug discovery, integrating computational modeling with preliminary chemical optimization to address diverse enzymatic pathways.

Top Research Directions

The 15 research directions with Journal of Enzyme Inhibition and Medicinal Chemistry 2018 papers, ranked by paper count, next to 2017. Share is the fraction of the edition’s papers in the direction.

#Direction20182017Share 2018Share 20172017 rank
1Modeling Molecular Dynamics Beyond Static Structural Snapshots2066.7%0.0%—
2Transforming Initial Chemical Hits into Potent Therapeutic Leads2066.7%0.0%—
33D Chemical Feature Mapping for Virtual Screening1033.3%0.0%—
4Bridging the Structure Property Gap in Novel Materials1033.3%0.0%—
5Computing Molecular Binding Free Energies1033.3%0.0%—
6Exploiting Cryptic Allosteric Sites for Selective Therapeutics1033.3%0.0%—
7Navigating the Combinatorial Complexity of Chemical Space1033.3%0.0%—
8Operando Spectroscopy for Dynamic Chemical Interfaces1033.3%0.0%—
9Optimizing Chemical Scaffolds for Therapeutic Efficacy1033.3%0.0%—
10Overcoming Off-Target Cross-Reactivity in Kinase Inhibitors1033.3%0.0%—
11Pharmacokinetic Filtering in Virtual Screening1033.3%0.0%—
12Rational Drug Discovery Through Fragment Elaboration1033.3%0.0%—
13Targeting Allosteric Sites for Selective Protein Modulation1033.3%0.0%—
14Template-Based Protein Structure Prediction1033.3%0.0%—
15The In Vitro to In Vivo Validation Gap1133.3%100.0%5

Download all directions as CSV

Institutions

Institutions credited by Journal of Enzyme Inhibition and Medicinal Chemistry 2018 papers: a paper credits every institution named in its affiliations, once. 10 institutions share 3 credited papers.

#InstitutionPapersShare20172017 rank
1University of Vienna 266.7%0—
2000y6ah26 133.3%0—
305hdkmf40 133.3%0—
4BOKU University 133.3%0—
5Cambridge Crystallographic Data Centre 133.3%0—
6Consejo Superior de Investigaciones Científicas 133.3%0—
7National Cancer Institute 133.3%0—
8Temple University 133.3%0—
9University of Cambridge 133.3%0—
10University of Pisa 133.3%0—

Download all institutions as CSV

About this data

Papers. Journal of Enzyme Inhibition and Medicinal Chemistry 2018 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2017 use shares, since the edition went from 1 to 3 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 3 of 3 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Enzyme Inhibition and Medicinal Chemistry 2018”, https://lacuna.tiptreesystems.com/venue/journal-of-enzyme-inhibition-and-medicinal-chemistry/2018.

Top Authors

AuthorPapers
Thierry Langer2

Impactful Papers

Papers from Journal of Enzyme Inhibition and Medicinal Chemistry 2018 that shaped research clusters.

Influential

Papers

Title
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors
Identification of new allosteric sites and modulators of AChE through computational and experimental tools
Pharmacophore-based discovery of 2-(phenylamino)aceto-hydrazides as potent eosinophil peroxidase (EPO) inhibitors